Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 07, 2024 09:00 ET | Source: AssistRx

Speranza Therapeutics and CoAssist Pharmacy join the fight against the opioid crisis through patient access to non-invasive therapy

Speranza Therapeutics announces a paramount partnership with CoAssist Pharmacy to improve patient access to S.T. Genesis.
August 07, 2024 09:00 ET | Source: PeopleOne Health

PeopleOne Health Expands Florida Operations with Opening of New Health Center in Palatka

ORLANDO, Fla., Aug. 07, 2024 (GLOBE NEWSWIRE) -- PeopleOne Health, a pioneer in value-based primary care, today announced the opening of its first health center in Palatka, Florida. Part of a...
August 07, 2024 09:00 ET | Source: Adial Pharmaceuticals, Inc

Adial Pharmaceuticals Announces Last Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Patient dosing has concluded for the second and last cohort of the pharmacokinetics study of AD04 Topline results expected during the fourth quarter GLEN ALLEN, Va., Aug. 07, 2024 (GLOBE NEWSWIRE)...
August 07, 2024 08:30 ET | Source: MarketsandMarkets Research Pvt. Ltd.

Veterinary Diagnostic Market: $3.3B to $5.0B Growth Forecast (2023-2029) | MarketsandMarkets™

Chicago, Aug. 07, 2024 (GLOBE NEWSWIRE) -- The "Veterinary Diagnostic Market Size, Share & Trends by Product (Instrument, Consumable), Technology (Immuno (ELISA, RIA, Lateral flow), Molecular...
August 07, 2024 08:00 ET | Source: Tr1X Bio

Tr1X Announces FDA Clearance of IND Application for TRX103, an Allogeneic Engineered Tr1 Treg Cell Therapy for Treatment-Refractory Crohn’s Disease

SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Tr1X, Inc. (pronounced “Trix”), a biopharmaceutical company specializing in allogeneic engineered Treg and CAR-Treg cell therapies with the potential to...
August 07, 2024 07:50 ET | Source: ZyVersa Therapeutics

ZyVersa Therapeutics Announces Published Data Supporting the Rationale for Inhibiting Inflammasome ASC with IC 100 to Control Chronic Inflammation

Extracellular ASC has a crucial role in aggregation and deposition of amyloid A fibrils leading to associated chronic inflammatory conditions.
August 06, 2024 20:30 ET | Source: Allied Analytics LLP

Dental 3D Printing Devices Market to Reach $52.2 Billion, Globally, by 2033 at 19.4% CAGR: Allied Market Research

Wilmington, Delaware, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Dental 3D Printing Devices Market by Equipment (3D Scanner and Printer), Technology...
August 06, 2024 18:51 ET | Source: ADC Therapeutics SA

ADC Therapeutics berichtet über Finanzergebnisse des zweiten Quartals 2024 und gibt aktuelle Informationen zum Geschäftsbetrieb bekannt

ZYNLONTA® – Nettoumsatz von 17,0 Mio. USD im 2. Quartal 2024; kommerzielle Rentabilität in der ersten Hälfte des Jahres 2024 erreicht Rekrutierung für die LOTIS-7-Studie verläuft planmäßig;...
August 06, 2024 17:30 ET | Source: Iterum Therapeutics PLC

Iterum Therapeutics Announces Expiration and Results of Rights Offering

DUBLIN and CHICAGO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on developing next generation oral and...
August 06, 2024 17:17 ET | Source: kneat.com, inc.

Kneat Announces Record Revenue for Second Quarter 2024

Kneat's Q2 2024 Growth Accelerates YoY, with Revenue up 45%, Annual Recurring Revenue up 60%, Gross Profit up 63%